KNOWING THE MOLECULAR HETEROGENEITY OF HUMAN PATHOGENIC VIRUSES: MY CONCERN AND YOUR HOPE

Professor Faruk Adamu Kuta

Wednessday 14th April, 2021

The Federal University of Technology Minna,
Main Campus,
Gidan Kwanu,
Minna, Niger State

Viral diseases ( Rotaviruses gastroenteritis, Liver cirrhosis/Hepatocellular carcinoma, Cervical, Breast and penal cancers) can best be controlled through prophylactic measures rather than curative measures. The need to identify the circulating genotypes/serotypes of Human pathogenic viruses (Rotaviruses, Hepatitis C viruses and Human papilloma viruses) for the development of an indigenous vaccine for the control of the viral diseases cannot be overemphasized, as there is no universally acceptable curative protocol in place for now. This is synonymous with the saying “prevention is better than cure”.
 
Viral diseases have brought about socioeconomic distress among developing nations and have hampered effective service delivery. Hence, the need for synergy between government and non-governmental organisations to fund researches that will target production of indigenous vaccines to be used for the control ofviral diseases.

There should be enabling laws to bring about strong collaborations between government, non-governmental organizations and universities in the area of funding researches targeted at identifying circulating genotypes/serotypes of most pathogenic viruses. The results of such researches will serve as a data for the development of indigenous vaccines, rather than importation of vaccines that may not serve the purpose it is meant.

Government should direct its attention towards the establishment of regional laboratories equipped with state-of-the-art facilities that will be used to address problems of diagnosis of viral diseases particularly during epidemics (See the case of Coronavirus Disease, 2019).